Rapid-diagnostics company Cue Health earned $223.7 million in revenue for the third quarter of 2021, compared with $137.4 million for the prior quarter and $4.7 million for the prior year.
The company went public in late September, raising $213.9 million in proceeds after underwriting fees.
Net income dipped slightly to $19.3 million compared with $19.8 million in the second quarter, and earnings...
Fitbit’s year-over-year device sales flatlined in Q3 2019, which combined with lower sales tag prices drove a decline in revenue, according to the wearables maker’s latest quarterly earnings.
The reporting — which was bereft of an investor’s call, Q&A and any forward-looking statements due to the company’s pending acquisition — is the latest look at a wearables business Google apparently...
On its third quarter earnings call last week, Dexcom recapped a busy Q3 — of note, one that included the acquisition of TypeZero Technologies for $11.3 million in August as well as two new FDA clearances in October and November. One of these clearances was for a new mobile app interface for the Dexcom G6 while the other was the Dexcom Pro Q CGM, a new disposable glucose monitoring device intended...
